Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
50
FSNUF Quote, Financials, Valuation and Earnings
Last price:
$55.90
Seasonality move
:
4.06%
Day range:
$55.90 - $55.90
52-week range:
$32.85 - $58.16
Dividend yield:
2.03%
P/E ratio:
24.73x
P/S ratio:
1.28x
P/B ratio:
1.44x
Volume:
--
Avg. volume:
121
1-year change:
61.3%
Market cap:
$31.5B
Revenue:
$23.6B
EPS (TTM):
$2.26
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Fresenius SE & Co. KGaA has -- downside to fair value with a price target of -- per share.
FSNUF vs. S&P 500
-
Over the past 5 trading days, Fresenius SE & Co. KGaA has underperformed the S&P 500 by -0.1% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Fresenius SE & Co. KGaA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Fresenius SE & Co. KGaA has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Fresenius SE & Co. KGaA reported revenues of $6.4B.
Earnings Growth
-
Fresenius SE & Co. KGaA has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Fresenius SE & Co. KGaA reported earnings per share of $0.71.
Enterprise value:
45.4B
EV / Invested capital:
1.18x
Price / LTM sales:
1.28x
EV / EBIT:
19.13x
EV / Revenue:
1.84x
PEG ratio (5yr expected):
0.05x
EV / Free cash flow:
35.83x
Price / Operating cash flow:
24.86x
Enterprise value / EBITDA:
12.53x
Gross Profit (TTM):
$6.2B
Return On Assets:
3.37%
Net Income Margin (TTM):
6.48%
Return On Equity:
7.33%
Return On Invested Capital:
4.35%
Operating Margin:
8.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $23.1B | $23.3B | $24.7B | $5.8B | $6.4B | |
| Gross Profit | $5.5B | $5.9B | $6.2B | $1.5B | $1.5B | |
| Operating Income | $1.4B | $2B | $2.4B | $536.1M | $543.4M | |
| EBITDA | $2.6B | $3.6B | $3.6B | $827.2M | $865.9M | |
| Diluted EPS | $0.11 | -$0.71 | $2.26 | $0.64 | $0.71 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $20.1B | $19B | $47.5B | $12.5B | $14.2B | |
| Total Assets | $82.4B | $78.7B | $79.8B | $47.3B | $49.9B | |
| Current Liabilities | $17.8B | $14.6B | $30.9B | $9.2B | $11.2B | |
| Total Liabilities | $49.7B | $45.2B | $47.7B | $25.6B | $27.2B | |
| Total Equity | $32.7B | $33.5B | $32.1B | $21.7B | $22.6B | |
| Total Debt | $28.6B | $26.4B | $15.8B | $13B | $12.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5B | $3.5B | $2.5B | $873.9M | $903.8M | |
| Cash From Investing | -$2.4B | -$2.2B | -$947.6M | -$124.8M | -$328M | |
| Cash From Financing | -$1.9B | -$2.5B | -$592.8M | -$367.7M | $720.8M | |
| Free Cash Flow | $3.5B | $2.4B | $1.3B | $602.8M | $546.1M | |
FSNUF
Sector
Market Cap
$31.5B
$27.9M
Price % of 52-Week High
96.11%
51.04%
Dividend Yield
2.03%
0%
Shareholder Yield
1.12%
-1.49%
1-Year Price Total Return
61.3%
-16.66%
Beta (5-Year)
0.646
0.516
Dividend yield:
2.03%
Annualized payout:
$0.00
Payout ratio:
-41.83%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$54.90
200-day SMA
Buy
Level
$48.30
Bollinger Bands (100)
Buy
Level
50.68 - 57.4
Chaikin Money Flow
Sell
Level
-4.4M
20-day SMA
Buy
Level
$54.13
Relative Strength Index (RSI14)
Buy
Level
63.02
ADX Line
Buy
Level
41.26
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$54.46
MACD (12, 26)
Buy
Level
0.20
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
13.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6484)
Sell
CA Score
(Annual)
Level (-0.3881)
Buy
Beneish M-Score
(Annual)
Level (-2.739)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.307)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
Stock Forecast FAQ
In the current month, FSNUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The FSNUF average analyst price target in the past 3 months is --.
-
Where Will Fresenius SE & Co. KGaA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Fresenius SE & Co. KGaA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Fresenius SE & Co. KGaA?
Analysts are divided on their view about Fresenius SE & Co. KGaA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Fresenius SE & Co. KGaA is a Sell and believe this share price will rise from its current level to --.
-
What Is Fresenius SE & Co. KGaA's Price Target?
The price target for Fresenius SE & Co. KGaA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is FSNUF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Fresenius SE & Co. KGaA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of FSNUF?
You can purchase shares of Fresenius SE & Co. KGaA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Fresenius SE & Co. KGaA shares.
-
What Is The Fresenius SE & Co. KGaA Share Price Today?
Fresenius SE & Co. KGaA was last trading at $55.90 per share. This represents the most recent stock quote for Fresenius SE & Co. KGaA. Yesterday, Fresenius SE & Co. KGaA closed at $55.90 per share.
-
How To Buy Fresenius SE & Co. KGaA Stock Online?
In order to purchase Fresenius SE & Co. KGaA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get FSNUF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FSNUF
Sector
P/E ratio
24.73x
23.85x
PEG ratio
0.05x
-0.01x
P/B ratio
1.44x
1.81x
Price / LTM sales
1.28x
1.58x
Growth Metrics
FSNUF
Sector
Revenue growth
9.78%
4.62%
Earnings growth
12.25%
10.7%
Revenue (5-year growth)
-9.84%
6.5%
Earnings forecast
--
-$0.21
Profitability
FSNUF
Sector
Profitability FY 2024
$5.8B
$3.6M
Return on invested capital
4.35%
-31.87%
Return on assets
3.37%
-28.18%
Return on equity
7.33%
-37.63%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
4
Balance Sheet
FSNUF
Sector
Total cash
$2.8B
$26.4M
Short term investments
--
$25.7M
Total assets
$45.1B
$76.9M
Long term debt
$12.9B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 22
Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.
Buy
54
BMRN alert for Dec 22
BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.
Buy
82
RKLB alert for Dec 22
Rocket Lab Corp. [RKLB] is up 9.97% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
